Chlamydia vaccine triggers immune response in early trial

A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).

Related Keywords

Denmark ,United States ,New York ,America ,Hilary Reno ,Jes Dietrich ,Jay Varma ,David Harvey ,National Coalition ,Louis County Sexual Health Clinic ,Us Centers For Disease ,Washington University School Of Medicine ,Disease Control ,Lancet Infectious Diseases ,Weill Cornell Medicine ,New York City ,Washington University School ,Louis County Sexual Health ,Statens Serum Institut ,Health ,Weill Cornell ,